4Bates D W,Cullen D,Laird N,et al. Incidence of adverse drug events and potential adverse drug events[ J ]. JAMA, 1995,274:29.
5Paoletti R D, Casey E W. Reducing costs through centralization and standardization of i. v. admixture program [ J ]. Am J Health Syst Pharm,2000,57 (12) :1147.
二级参考文献9
1吴蓬.药事管理学[M].北京：人民卫生出版社,1993.52.
2[1]Schumock G, Walton S, Sarawate C, et al. Pharmaceutia services in rural hospitals in Illinois-2001[J]. Am J Health Syst Pharm, 2003, 60(7) :566.
3[2]Thompson KK. Nursing and pharnacy agree:it is time for change[J].Am J Health Syst Pharm,2003,60(10) :993.
4[3]Galindo C, Olive M, Lacasa C, et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital [ J ]. Pharm World Sci,2003,25(2) :56.
5[4]Hayashi S. The expected role of community pharmacist in society[J].Yakugaku Zasshi,2003, 123(3): 163.
6[5]Milkovich G, Saetrum 0. The role of hospital pharmacist in cost control and sntibiotic policy[J]. Int J Antimicrob Agents,2000, 16(3) :291.
7[6]Paoletti RD, Casey EW. Reducing costs through centralization and standardization of an i.v. admixture program[ J]. Am J Health $yst Pharm,2000,57(12): 1147.
8[7]Travlos DV, Zarembski DG. Standards for continuing pharmacy educa tion: role of the American Council on Pharmacetical Education[J]. Am J Healthe Syst Pharm,2003,60(9) :940.
9Richard J. Plumridge and Michael Maher. Justification of a pharmacy intravenous admixture service in an Australian hospital[J],Am J Hosp Pharm, 1993,50(3) :463.
